TDL GENETICS LIMITED

Active London

Other human health activities

10 employees website.com
Life sciences and medical technology Other human health activities
T

TDL GENETICS LIMITED

Other human health activities

Founded 24 Mar 2000 Active London, England 10 employees website.com
Life sciences and medical technology Other human health activities

Previous Company Names

CYTOGENETIC DNA SERVICES LIMITED 15 May 2000 — 4 Jul 2013
CYTOGENETIC SERVICES LIMITED 24 Mar 2000 — 15 May 2000
Accounts Submitted 11 Apr 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 11 Sept 2025 Next due 15 Sept 2026 3 months remaining
Net assets £6M £16M 2025 year on year
Total assets £9M £18M 2025 year on year
Total Liabilities £3M £1M 2025 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

The Halo Building 1 Mabledon Place London WC1H 9AX England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for TDL GENETICS LIMITED (03959656), an active life sciences and medical technology company based in London, England. Incorporated 24 Mar 2000. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type full
Next accounts 30 Jun 2025
Due by 31 Mar 2026 2 months overdue

Balance Sheet & P&L (2014–2025)

Cash in Bank

£776.00k

Decreased by £438.00k (-36%)

Net Assets

£5.96M

Decreased by £16.46M (-73%)

Total Liabilities

£2.60M

Decreased by £1.33M (-34%)

Turnover

£12.96M

Increased by £716.00k (+6%)

Employees

10

Increased by 1 (+11%)

Debt Ratio

30%

Increased by 15 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Alexander, Paul JosephSecretaryAustralianUnknown29 Jul 2003Active
Levett, Lisa, DrDirectorBritishEngland546 Apr 2000Active

Shareholders

Shareholders (1)

Sonic Healthcare Holding Company
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

TDL GENETICS LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
35 Devonshire Street, (W1N 1RF) CITY OF WESTMINSTER
Leasehold-8 Nov 2002
35 Devonshire Street, (W1N 1RF)
Leasehold
Added 8 Nov 2002
District CITY OF WESTMINSTER

Documents

Company Filings

DateCategoryDescriptionDocument
11 Apr 2026AccountsAnnual accounts made up to 30 Jun 2025
11 Dec 2025OfficersAppointment of Dr James Pacey Newcombe as director on 20 Nov 2025
3 Dec 2025OfficersTermination of Colin Stephen Goldschmidt as director on 20 Nov 2025
11 Sept 2025Confirmation StatementConfirmation statement made on 1 Sept 2025 with no updates
4 Apr 2025AccountsAnnual accounts made up to 30 Jun 2024
11 Apr 2026 Accounts

Annual accounts made up to 30 Jun 2025

11 Dec 2025 Officers

Appointment of Dr James Pacey Newcombe as director on 20 Nov 2025

3 Dec 2025 Officers

Termination of Colin Stephen Goldschmidt as director on 20 Nov 2025

11 Sept 2025 Confirmation Statement

Confirmation statement made on 1 Sept 2025 with no updates

4 Apr 2025 Accounts

Annual accounts made up to 30 Jun 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

1 months ago on 11 Apr 2026

Appointment of Dr James Pacey Newcombe as director on 20 Nov 2025

5 months ago on 11 Dec 2025

Termination of Colin Stephen Goldschmidt as director on 20 Nov 2025

5 months ago on 3 Dec 2025

Confirmation statement made on 1 Sept 2025 with no updates

8 months ago on 11 Sept 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 4 Apr 2025